St. Jude Children’s Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children.
The St. Jude Brain Tumor Program is one of the largest clinical brain tumor programs in North America, with experts representing pediatric oncology, neuro-oncology, neurosurgery, radiation oncology, neuroradiology, neuro-pathology and neuropsychology. The team collaborates with world leading neuroscientists, cancer biologists and physicians from the St. Jude Neurobiology and Brain Tumor Program to advance understanding of the biology of normal and malignant growth in the nervous system. This knowledge is translated rapidly into Phase I, Phase II and Phase III therapeutic clinical trials for the most common and lethal forms of childhood brain tumors. Novel St. Jude brain tumor studies are currently ongoing in infant CNS tumors, medulloblastoma, malignant gliomas and localized, low-grade neoplasms. Additionally, the program has developed an active long-term follow-up effort that helps identify, treat and study the late sequelae of disease and treatment for childhood brain tumors.
Clinical trials for the brain tumor program at St. Jude are also developed in collaboration with other strong pediatric neuro-oncology programs, cooperative groups, the Children’s Oncology Group and the Pediatric Brain Tumor Consortium.
St. Jude provides safe, healthy, tranquil and family-oriented lodging for patient families who live more than 35 miles from the hospital when the patient’s treatment requires an overnight stay. Preserving a home-like family environment in one of the St. Jude-sponsored lodging facilities helps to reduce as much stress as possible during a difficult time.
Tri Delta Place – a short-term lodging facility for St. Jude patients and families who need lodging for 1-7 days.
Ronald McDonald House – a mid-term facility for St. Jude patients and families who need lodging for 8-90 days.
Target House – a long-term facility for St. Jude patients and families who need lodging for 90 days or more. For more information, please call 1-866-2ST-JUDE (1-866-278-5833) and ask for Patient Services.
For more information, please call 1-866-2ST-JUDE (1-866-278-5833) and ask for Patient Services
Amar Gajjar, MD
Principal Investigator, Pediatric Neuro-Oncologist
Christopher Tinkle, MD PhD
Co-Principal Investigator, Assistant Member, St. Jude Faculty